Table 2 Baseline predictors of treatment success (viral load<400 copies) among HIV-infected infants 6 months after ART initiation
From: Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda
Characteristic | Univariate OR | P-value | Multivariable OR | P-value |
|---|---|---|---|---|
(95% CI) | (95% CI) | |||
Age (>6 months) | 0.83 (0.31-2.24) | 0.718 | 1.20 (0.33-4.37) | 0.785 |
Sex (Male) | 1.01 (0.37-2.74) | 0.990 | 0.77 (0.24-2.45) | 0.657 |
CD4 percent (every 1%) | 0.99 (0.94-1.04) | 0.670 | 0.95 (0.89-1.01) | 0.123 |
WHO stage (stage3&4) | 0.43 (0.15-1.23) | 0.116 | 0.33 (0.08-1.14) | 0.078 |
Protease Inhibitor | 1.34 (0.45-4.02) | 0.603 | 1.33 (038-4.65) | 0.657 |
Weight for Age Z-score (<-2) | 0.63 (0.21-1.85) | 0.395 | 0.40 (0.09-1.76) | 0.227 |
Height for age Z-score (<-2) | 1.44 (0.50-4.12) | 0.500 | 2.08 (0.58-7.47) | 0.260 |